Two Sigma Investments’s Grace Therapeutics GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$273K Buy
126,791
+29,901
+31% +$66.4K ﹤0.01% 4396
2026
Q2
$220K Buy
+96,890
New +$268K ﹤0.01% 4726

Other funds holding GRCE

Two Sigma Investments's GRCE Position: Q3 2026 in Review

Two Sigma Investments increased its Grace Therapeutics (GRCE) stake by 31% in Q3 2026, buying an estimated $66.4K and bringing the position to 126,791 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #4396.

Two Sigma Investments first reported a position in GRCE in Q2 2026 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold GRCE as of Q3 2026.

  • Two Sigma Investments held 126,791 shares of Grace Therapeutics worth $273K as of Q3 2026.
  • Two Sigma Investments bought 29,901 Grace Therapeutics shares in Q3 2026, an estimated $66.4K.
  • Grace Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #4396 holding.
  • Two Sigma Investments first reported a position in Grace Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.